Related Experiment Videos
Human mast cell beta-tryptase is a gelatinase
Ignacio Fajardo1, Gunnar Pejler
1Department of Veterinary Medical Chemistry, The Biomedical Center, Uppsala, Sweden.
Journal of Immunology (Baltimore, Md. : 1950)
|July 23, 2003
Summary
Human mast cell beta-tryptase degrades gelatin and collagen, suggesting a role in extracellular matrix remodeling during inflammation and healing. This protease may contribute to connective tissue degradation in diseases like rheumatoid arthritis.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Extracellular matrix (ECM) remodeling is crucial in inflammation, wound healing, and angiogenesis.
- Matrix metalloproteinases (MMPs) like gelatinases A and B are known ECM degraders.
- Mast cells are implicated in connective tissue disorders, including rheumatoid arthritis.
Purpose of the Study:
- To investigate the ECM-degrading potential of human mast cell beta-tryptase.
- To determine if beta-tryptase contributes to matrix degradation beyond known MMPs.
Main Methods:
- Enzymatic assays using purified human beta-tryptase.
- Gelatin zymography.
- Degradation studies with gelatin and partially denatured collagen type I.
- Analysis of beta-tryptase-gelatin complex formation using SDS-PAGE.
Main Results:
- Human beta-tryptase demonstrated potent gelatin-degrading activity in solution and zymography.
- Beta-tryptase degraded partially denatured collagen type I.
- Strong binding of beta-tryptase to gelatin formed stable high molecular weight complexes.
- Mast cells store active beta-tryptase in granules, positioning it for in vivo activity.
Conclusions:
- Human beta-tryptase possesses significant gelatin-degrading capabilities.
- Beta-tryptase may play a role in ECM degradation, complementing MMP activity.
- Its presence in mast cells suggests a contribution to connective tissue remodeling in inflammatory diseases.